Europe taking on novel products as it aims for a ‘tobacco-free environment’

A European Council recommendation due in the autumn will be “a recommendation for a tobacco-free environment, regardless of the form tobacco takes,” European Commission public health director John Ryan told a high-level Brussels meeting on the implementation of the EU Beating Cancer Plan (Beca) and the Non-Communicable Diseases Initiative.

Ryan, acting deputy director-general of the Directorate General for Health and Food Safety (DG-Santé), said Europe was at the forefront of the fight against smoking and was now seriously tackling new products, including e-cigarettes and smokeless tobacco products. “We want to map the situation to see where the gaps are,” he said.

Council recommendations include strengthening rules on exposure to passive smoking, especially in the entertainment sector.

Ryan told the European Parliament Committee on the Environment, Public Health and Food Safety (ENVI) that more restrictive measures for novel tobacco products would come through the ongoing revision of the European Tobacco Products Directive (TPD) and the Tobacco Advertising Directive (TAD), while a “third lever” would be taxation.

“We are currently revising this regulation [the Tobacco Excise Directive (TED)],” Ryan said. “There are certainly new products that are intended to fall under this excise duty regulation. The first results are probably expected in the autumn.

“We are adding the final touches to this document, which will be sent to Parliament and then published so that everyone can follow the progress. This list will be available in its final version in the coming weeks.”


Subscribe to our Newsletter

Join in to hear about news, events, and podcasts in the sector

    See more

    A model for other diseases


    Ryan said the Beca was a model for approaches to other non-communicable diseases, particularly diabetes and cardiovascular disease. Committee member Véronique Trillet-Lenoir of the Renew Europe group confirmed: “What we achieve in oncology, we achieve in other areas of medicine. Other non-communicable diseases should benefit from the advances against cancer.”

    She pleaded for a European strategy for the prevention of non-communicable diseases to free the process from the pressures of “influential groups”.

    Ryan said the risk factors for cardiovascular disease included smoking, physical inactivity and alcohol similar determinants to those for cancer.

    “There are strong links between the cancer plan and what we can do elsewhere,” he stressed. “If you do something against cancer, it often has positive effects elsewhere. It is about preventing cancer but also other non-communicable diseases, which represent 80% of the diseases that are a problem today.”

    Sonia Romero TobaccoIntelligence contributing writer

    Photo: Wikimedia Commons

    Author default picture


    This article was written by one of TobaccoIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual nicotine markets.

    Our Key Benefits

    The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

    TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

    • Stay informed of any legal and market change in the sector that impacts your organisation
    • Maximise resources by getting market and legal data analysis daily in one place
    • Make smart decisions by understanding how the regulatory and market landscape evolves
    • Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation